Related Experiment Video
Updated: Jun 14, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Antifungal prophylaxis and treatment in patients with hematological malignancies
1Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong. ghwang@graduate.hku.hk
Abstract:
Invasive fungal infection (IFI) is a serious and common complication in hematological patients. The risk is highest among acute leukemia patients undergoing induction chemotherapy and patients undergoing allogeneic hematopoietic stem-cell transplantation. Owing to the difficulty in diagnosing IFIs and the fatality rate associated with delayed treatment, antifungal prophylaxis and empirical antifungal therapy are standard management approaches. Novel agents, such as posaconazole and echinocandins, broaden our armamentarium against IFIs and improve patients' outcomes.
Related Concept Videos
Cryptococcal Meningitis
Antifungal Agents
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Inhibitors of Viral Protein Synthesis
Treatment Resistent Cancers
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...